Summit Therapeutics Inc. (SMMT) › Shareholders' EquitySummit Therapeutics Inc. (SMMT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$3.59M2019: $78.86M2020: $79.45M2021: $83.28M2022: $126.65M2023: $77.69M2024: $388.75M2025: $658.86M$658.86M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$658.86M+69.5%2024$388.75M+400.4%2023$77.69M-38.7%2022$126.65M+52.1%2021$83.28M+4.8%2020$79.45M+0.7%2019$78.86M+2297.4%2018-$3.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share